Cargando…

New perspectives of biomarkers for the management of chronic hepatitis B

With recent advances in molecular and genomic investigations, the impact of hepatitis B viral and host factors on the progression of chronic HBV infection has been explored. For viral factors, hepatitis B viral load is a strong predictor for liver disease progression. Hepatitis B viral kinetics appe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Chih-Lin, Kao, Jia-Horng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266347/ https://www.ncbi.nlm.nih.gov/pubmed/28081591 http://dx.doi.org/10.3350/cmh.2016.0069

Ejemplares similares

Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection
por: Lin, Chih-Lin, et al.
Publicado: (2023)

Molecular Epidemiology of Hepatitis B Virus
por: Kao, Jia-Horng
Publicado: (2011)

Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog
por: Tseng, Tai-Chung, et al.
Publicado: (2012)

Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance
por: Yang, Hung-Chih, et al.
Publicado: (2014)

New Biomarkers of Chronic Hepatitis B
por: Mak, Lung-Yi, et al.
Publicado: (2019)

Three heads are better than two: Hepatitis B core-related antigen as a new predictor of hepatitis B virus-related hepatocellular carcinoma
por: Wu, Jer-Wei, et al.
Publicado: (2021)

Novel biomarkers for the management of chronic hepatitis B
por: Inoue, Takako, et al.
Publicado: (2020)

Safety considerations for withdrawal of nucleos(t)ide analogues in patients with chronic hepatitis B: First, do no harm
por: Hsu, Yao-Chun, et al.
Publicado: (2023)

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
por: Liaw, Yun-Fan, et al.
Publicado: (2008)

Novel Biomarkers of Hepatitis B Virus and Their Use in Chronic Hepatitis B Patient Management
por: Vachon, Alicia, et al.
Publicado: (2021)

The role of different viral biomarkers on the management of chronic hepatitis B
por: Mak, Lung-Yi, et al.
Publicado: (2023)

Evidence for Benefits of Early Treatment Initiation for Chronic Hepatitis B
por: Lim, Young-Suk, et al.
Publicado: (2023)

Noninvasive Diagnosis of Hepatic Fibrosis in Hemodialysis Patients with Hepatitis C Virus Infection
por: Liu, Chen-Hua, et al.
Publicado: (2022)

Elimination of Hepatitis B: Is It a Mission Possible?
por: Tseng, Tai-Chung, et al.
Publicado: (2017)

New approaches in the management of chronic hepatitis B: role of tenofovir
por: Reijnders, Jurriën GP, et al.
Publicado: (2009)

Pan-genotypic direct-acting antivirals for patients with hepatitis C virus infection and chronic kidney disease stage 4 or 5
por: Liu, Chen-Hua, et al.
Publicado: (2022)

Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection
por: Liu, Chen-Hua, et al.
Publicado: (2017)

Acute hepatitis C virus infection: clinical update and remaining challenges
por: Liu, Chen-Hua, et al.
Publicado: (2023)

Hepatitis B Virus DNA Integration Drives Carcinogenesis and Provides a New Biomarker for HBV-related HCC
por: Yeh, Shiou-Hwei, et al.
Publicado: (2023)

Prevention and Management of Chronic Hepatitis B
por: Bhat, Mamatha, et al.
Publicado: (2014)

Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfa
por: Liu, Chen-Hua, et al.
Publicado: (2014)

Unmet need in chronic hepatitis B management
por: Liang, Lilian Yan, et al.
Publicado: (2019)

Management of Antiviral Resistance in Chronic Hepatitis B
por: Lim, Young-Suk
Publicado: (2017)

Combination Therapy for Chronic Hepatitis B: Current Updates and Perspectives
por: Su, Tung-Hung, et al.
Publicado: (2017)

Persistent Hepatitis B Viral Replication in a FVB/N Mouse Model: Impact of Host and Viral Factors
por: Chen, Shih-Hui, et al.
Publicado: (2012)

Managing chronic hepatitis B: A qualitative study exploring the perspectives of people living with chronic hepatitis B in Australia
por: Wallace, Jack, et al.
Publicado: (2011)

Molecular Mechanism and Treatment of Viral Hepatitis-Related Liver Fibrosis
por: Su, Tung-Hung, et al.
Publicado: (2014)

New Approaches to the Treatment of Chronic Hepatitis B
por: Alexopoulou, Alexandra, et al.
Publicado: (2020)

Review article: switching patients with chronic hepatitis B to tenofovir alafenamide—a review of current data
por: Lim, Young‐Suk, et al.
Publicado: (2022)

A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection
por: Tong, Myron John, et al.
Publicado: (2010)

Hepatitis B reactivation: A possible cause of coronavirus disease 2019 vaccine induced hepatitis
por: Wu, Hsin-Yun, et al.
Publicado: (2023)

Recent Advances in the Management of Chronic Hepatitis B
por: Kim, Soo Ryang, et al.
Publicado: (2011)

Management of chronic hepatitis B during pregnancy
por: Aslam, Aysha, et al.
Publicado: (2018)

A Practical Approach to Management of Chronic Hepatitis B
por: Hu, Ke-Qin
Publicado: (2005)

Management of Chronic Hepatitis B in HIV-Coinfected Patients
por: Fasano, Massimo, et al.
Publicado: (2022)

Risk Factors and Biomarkers for Chronic Hepatitis B Associated Hepatocellular Carcinoma
por: Pandyarajan, Vijay, et al.
Publicado: (2021)

Advances in new antivirals for chronic hepatitis B
por: Tang, Yanhua, et al.
Publicado: (2022)

Host Genetic Factors Affecting Spontaneous HBsAg Seroclearance in Chronic Hepatitis B Patients
por: Cheng, Huei-Ru, et al.
Publicado: (2013)

The use of transient elastography in the management of chronic hepatitis B
por: Fung, James, et al.
Publicado: (2011)

KASL clinical practice guidelines: management of chronic hepatitis B
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_t6gq8ggot5ek1s932g4l32jv4b